Persistent perfusion abnormalities at day 1 correspond to different clinical trajectories after stroke

J Neurointerv Surg. 2023 Sep;15(e1):e26-e32. doi: 10.1136/neurintsurg-2022-018953. Epub 2022 Jun 14.

Abstract

Background: Perfusion abnormalities after thrombolysis are frequent within and surrounding ischemic lesions, but their relative frequency is not well known.

Objective: To describe the different patterns of perfusion abnormalities observed at 24 hours and compare the characteristics of the patients according to their perfusion pattern.

Methods: From our thrombolysis registry, we included 226 consecutive patients with an available arterial spin labeling (ASL) perfusion sequence at day 1. We performed a blinded assessment of the perfusion status (hypoperfusion-h, hyperperfusion-H, or normal-N) in the ischemic lesion and in the surrounding tissue. We compared the time course of clinical recovery, the rate of arterial recanalization, and hemorrhagic transformations in the different perfusion profiles.

Results: We identified seven different perfusion profiles at day 1. Four of these (h/h, h/H, H/H, and H/N) represented the majority of the population (84.1%). The H/H profile was the most frequent (34.5%) and associated with 3-month good outcome (modified Rankin Scale (mRS): 63.5%). Patients with persistent hypoperfusion within and outside the lesion (h/h, 12.4%) exhibited worse outcomes after treatment (mRS score 0-2: 23.8%) than other patients, were less frequently recanalized (40.7%), and had more parenchymal hematoma (17.8%). The h/H profile had an intermediate clinical trajectory between the h/h profile and the hyperperfused profiles.

Conclusion: ASL hypoperfusion within the infarct and the surrounding tissue was associated with poor outcome. A more comprehensive view of the mechanisms in the hypoperfused surrounding tissue could help to design new therapeutic approaches during and after reperfusion therapies.

Keywords: MR perfusion; Stroke; Thrombolysis.

MeSH terms

  • Brain Ischemia* / complications
  • Humans
  • Perfusion
  • Reperfusion
  • Spin Labels
  • Stroke* / complications
  • Stroke* / diagnostic imaging
  • Stroke* / therapy
  • Thrombolytic Therapy
  • Treatment Outcome

Substances

  • Spin Labels